...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - Jan 7, 2016 - Details

Maybe I forgot a past deal or something,but what does don mean when he says he sold 19.5 million shares at $1.00/share, if you know KBC or anyone? Was that the China or other buy ins? Thanks jk

The quote in masila's post was "We've been able to raise $19.5M USD over the past year."

All I see are the private placements, which are typically announced.

http://www.zenithepigenetics.com/newsroom/news-releases.html

Total is 16.6 million USD in the past 2 years. That might work out to be 19.5 million CAD.

So I'm guessing Don is referring to 19.5 million CAD raised over the last 2 years.

Share
New Message
Please login to post a reply